United Health Products' HemoStyp™ Featured in Dentistry Today

Colts Neck, NJ – January 22, 2013 – United Health Products, Inc.(OTCQB:UEEC) which develops and markets products and technologies in the healthcare sector, today announced that UHP's hemostatic gauze, which is registered and branded in the USA under the trademark HemoStyp™, has been featured in the January 2013 edition of Dentistry Today. The article states that while there are other "hemostatic agents available to the dental practitioner, most of them are difficult to place, difficult to keep in position, and difficult to remove without disturbing the clotted surface, thereby reinitiating the bleeding. This specifically formulated gauze produces hemostasis almost instantly when positioned on a cut or wound. It contains no potentially harmful chemicals such as thrombin, collagen, or animal byproducts, is hypoallergenic, and works more quickly than other hemostatic agents. Once it has completed its task, it is readily dissolved by saline solution or water for easy removal that neither disturbs the clotted surface nor encourages re-bleeding." Dentistry Today is a top dental industry report offering comprehensive coverage of the latest news and developing technologies from within the dental industry through both print and online offerings. 

Dr. Phillip Forman, CEO of United Health Products Inc., stated that "the coverage of our product by Dentistry Today continues to validate the HemoStyp™ gauze and our marketing efforts for its use within the dental industry." Dr. Forman went on to say that "In addition to Dentistry Today, our product was also highlighted several times in the last few months in the Clinicians Report® , another well known dental industry publication." In the December issue of the Clinicians Report®HemoStyp™ was listed among the "Best Products Evaluated During 2012" with 83% of the evaluators stating that they would recommend the product. The company has received an initial order from one of the dental industry’s largest dental products distributors. Dr. Forman further states that he hopes that the continued coverage and testimony by multiple industry publications generates the same kind of interest in the product. The January 2013 issue of Dentistry Today can be purchased or viewed at the following link for a nominal fee – www.dentistrytoday.com

About United Health Products, Inc.
United Health Products, Inc. (UEEC) develops, manufactures, and markets a patent pending hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp™, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on ramping up sales in its current markets as well as identifying new markets and applications for its products and technologies. For more information on United Health Products, Inc. please visit: www.unitedhealthproductsinc.com.

Safe Harbor Statement 
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements 

Contact:
United Health Products, Inc.
Dr. Phillip Forman, 732-239-3444
CEO